John Trizzino Insider Trading for February 2021
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for John Trizzino.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Overview of insider trading of John Trizzino for February 2021.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Feb 09 2021 | NVAX | NOVAVAX INC | Trizzino John | EVP, Chief Commerci ... | Option Exercise | M | 5.95 | 384 | 2,285 | 12,267 | |
Feb 09 2021 | NVAX | NOVAVAX INC | Trizzino John | EVP, Chief Commerci ... | Option Exercise | M | 5.95 | 2,084 | 12,400 | 66,667 | |
Feb 09 2021 | NVAX | NOVAVAX INC | Trizzino John | EVP, Chief Commerci ... | Option Exercise | M | 46.00 | 521 | 23,966 | 11,986 | |
Feb 09 2021 | NVAX | NOVAVAX INC | Trizzino John | EVP, Chief Commerci ... | Option Exercise | M | 27.60 | 417 | 11,509 | 4,592 | |
Feb 09 2021 | NVAX | NOVAVAX INC | Trizzino John | EVP, Chief Commerci ... | Sell | S | 324.50 | 194 | 62,953 | 287 | 481 to 287 (-40.33 %) |
Feb 09 2021 | NVAX | NOVAVAX INC | Trizzino John | EVP, Chief Commerci ... | Payment of Exercise | F | 290.18 | 182 | 52,813 | 481 | 663 to 481 (-27.45 %) |
Feb 09 2021 | NVAX | NOVAVAX INC | Trizzino John | EVP, Chief Commerci ... | Sell | D | 290.18 | 8 | 2,321 | 663 | 671 to 663 (-1.19 %) |
Feb 09 2021 | NVAX | NOVAVAX INC | Trizzino John | EVP, Chief Commerci ... | Buy | M | 5.95 | 384 | 2,285 | 671 | 287 to 671 (+133.80 %) |
Feb 09 2021 | NVAX | NOVAVAX INC | Trizzino John | EVP, Chief Commerci ... | Sell | S | 298.80 | 25 | 7,470 | 287 | 312 to 287 (-8.01 %) |
Feb 09 2021 | NVAX | NOVAVAX INC | Trizzino John | EVP, Chief Commerci ... | Sell | S | 297.82 | 30 | 8,935 | 312 | 342 to 312 (-8.77 %) |
Feb 09 2021 | NVAX | NOVAVAX INC | Trizzino John | EVP, Chief Commerci ... | Sell | S | 296.96 | 104 | 30,884 | 342 | 446 to 342 (-23.32 %) |
Feb 09 2021 | NVAX | NOVAVAX INC | Trizzino John | EVP, Chief Commerci ... | Sell | S | 296.01 | 238 | 70,451 | 446 | 684 to 446 (-34.80 %) |
Feb 09 2021 | NVAX | NOVAVAX INC | Trizzino John | EVP, Chief Commerci ... | Sell | S | 295.05 | 625 | 184,404 | 684 | 1.3 K to 684 (-47.75 %) |
Feb 09 2021 | NVAX | NOVAVAX INC | Trizzino John | EVP, Chief Commerci ... | Sell | S | 293.96 | 405 | 119,054 | 1,309 | 1.7 K to 1.3 K (-23.63 %) |
Feb 09 2021 | NVAX | NOVAVAX INC | Trizzino John | EVP, Chief Commerci ... | Sell | S | 292.91 | 272 | 79,670 | 1,714 | 2 K to 1.7 K (-13.70 %) |
Feb 09 2021 | NVAX | NOVAVAX INC | Trizzino John | EVP, Chief Commerci ... | Sell | S | 291.79 | 117 | 34,139 | 1,986 | 2.1 K to 2 K (-5.56 %) |
Feb 09 2021 | NVAX | NOVAVAX INC | Trizzino John | EVP, Chief Commerci ... | Sell | S | 290.86 | 57 | 16,579 | 2,103 | 2.2 K to 2.1 K (-2.64 %) |
Feb 09 2021 | NVAX | NOVAVAX INC | Trizzino John | EVP, Chief Commerci ... | Sell | S | 289.45 | 55 | 15,920 | 2,160 | 2.2 K to 2.2 K (-2.48 %) |
Feb 09 2021 | NVAX | NOVAVAX INC | Trizzino John | EVP, Chief Commerci ... | Sell | S | 287.03 | 30 | 8,611 | 2,215 | 2.2 K to 2.2 K (-1.34 %) |
Feb 09 2021 | NVAX | NOVAVAX INC | Trizzino John | EVP, Chief Commerci ... | Sell | S | 284.82 | 25 | 7,121 | 2,245 | 2.3 K to 2.2 K (-1.10 %) |
Feb 09 2021 | NVAX | NOVAVAX INC | Trizzino John | EVP, Chief Commerci ... | Sell | S | 283.50 | 1,020 | 289,171 | 2,270 | 3.3 K to 2.3 K (-31.00 %) |
Feb 09 2021 | NVAX | NOVAVAX INC | Trizzino John | EVP, Chief Commerci ... | Sell | S | 282.00 | 19 | 5,358 | 3,290 | 3.3 K to 3.3 K (-0.57 %) |
Feb 09 2021 | NVAX | NOVAVAX INC | Trizzino John | EVP, Chief Commerci ... | Buy | M | 5.95 | 2,084 | 12,400 | 3,309 | 1.2 K to 3.3 K (+170.12 %) |
Feb 09 2021 | NVAX | NOVAVAX INC | Trizzino John | EVP, Chief Commerci ... | Buy | M | 46.00 | 521 | 23,966 | 1,225 | 704 to 1.2 K (+74.01 %) |
Feb 09 2021 | NVAX | NOVAVAX INC | Trizzino John | EVP, Chief Commerci ... | Buy | M | 27.60 | 417 | 11,509 | 704 | 287 to 704 (+145.30 %) |